Crypto Analyst Challenges Ripple’s CEO on Strategy Model
A crypto analyst challenges Ripple’s CEO over Strategy’s BTC funding model as BTC and XRP markets react to evolving f...
What To Do If Someone Asks For Seed Phrase
If someone asks for your seed phrase, do not reveal it. This article explains practical steps to protect your accounts and verify legitimate requests.
10,733 articlesKalshi Faces Class Action Over Khamenei Market Payout
A new class action filed in California claims Kalshi misled traders in a Khamenei leadership prediction market, resul...
If You Have $850,000 Saved Here, What Comes Next?
With $850,000 saved at 59, a couple can expect about $2,600-$2,800 a month in early retirement from portfolios, befor...
Tech Stocks March: 3 Top Buys to Consider in March 2026
As earnings season winds down, March can be a smart time to add leading tech stocks to your portfolio. Explore three ...
Seagate Surges 250% YTD: Does Seagate Have More Upside?
Seagate Technology has rallied about 250% year-to-date as AI storage demand accelerates. This update weighs whether t...
Justifying a $1.5 Trillion SpaceX IPO Valuation in Markets
SpaceX faces a towering IPO target: a $1.5 trillion market cap. Analysts say the math hinges on unprecedented growth ...
California’s Pays Monthly Tax-Free ETF for High Earners
For California residents in the top tax brackets, the Invesco California AMT-Free Municipal Bond ETF PWZ continues to...
Jerome Powell's Warning Wall Signals Potential Market Shift
Powell's warning to Wall Street is shaping market expectations as AI optimism runs high. This article breaks down wha...
Lionel Richie’s Ex-Wife Says He’s OK After Health Scare
A high-profile health scare on stage sparked a ripple of financial questions for touring acts and self-employed profe...
KAST Raises $80M Series a to Accelerate Global Expansion
KAST announces an $80 million Series A led by QED Investors and Left Lane Capital, valuing the stablecoin fintech at ...
VYM Delivers 200% Over a Decade, Yet Income Costs Rising
VYM has posted strong long-term gains, delivering around 200% over 10 years. Yet its income yield lags behind more in...
UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status